Non-alcoholic fatty liver disease and cardiovascular risk: an update
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-alcoholic fatty liver disease and cardiovascular risk: an update
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume 12, Issue 12, Pages 1175-1177
Publisher
Informa UK Limited
Online
2018-10-16
DOI
10.1080/17474124.2018.1533117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction
- (2018) Olubunmi O. Olubamwo et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study
- (2018) Alina M. Allen et al. HEPATOLOGY
- The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe
- (2018) Tracey G. Simon et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Improved management of patients after acute coronary syndrome: using nonalcoholic fatty liver disease fibrosis score and ezetimibe?
- (2018) Jan Pitha INTERNATIONAL JOURNAL OF CARDIOLOGY
- Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men
- (2018) Jung Eun Lee et al. PLoS One
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
- (2016) Niki Katsiki et al. Current Vascular Pharmacology
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
- (2015) Mohammad S. Siddiqui et al. Clinical Gastroenterology and Hepatology
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study
- (2015) Jessica L. Mellinger et al. JOURNAL OF HEPATOLOGY
- Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
- (2014) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
- (2013) Matti J. Tikkanen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Nonalcoholic fatty liver disease is associated with coronary artery calcification
- (2012) Donghee Kim et al. HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now